The global Radioembolization Microsphere market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Radioembolization microspheres are a medical method that combines radiotherapy with embolization and is mainly used to treat liver malignant tumors.
This report studies the global Radioembolization Microsphere production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radioembolization Microsphere, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioembolization Microsphere that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radioembolization Microsphere total production and demand, 2019-2030, (K Units)
Global Radioembolization Microsphere total production value, 2019-2030, (USD Million)
Global Radioembolization Microsphere production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radioembolization Microsphere consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Radioembolization Microsphere domestic production, consumption, key domestic manufacturers and share
Global Radioembolization Microsphere production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Radioembolization Microsphere production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radioembolization Microsphere production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Radioembolization Microsphere market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Quirem Medical, ABK Biomedical and Chengdu New Radiomedicine Technology Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioembolization Microsphere market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Radioembolization Microsphere Âé¶¹Ô´´, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Radioembolization Microsphere Âé¶¹Ô´´, Segmentation by Type
Holmium 166 Microspheres
Yttrium 90 Microspheres
Others
Global Radioembolization Microsphere Âé¶¹Ô´´, Segmentation by Application
Liver Tumors
Liver Cancer
Others
Companies Profiled:
Boston Scientific
Quirem Medical
ABK Biomedical
Chengdu New Radiomedicine Technology Co.,Ltd.
Key Questions Answered
1. How big is the global Radioembolization Microsphere market?
2. What is the demand of the global Radioembolization Microsphere market?
3. What is the year over year growth of the global Radioembolization Microsphere market?
4. What is the production and production value of the global Radioembolization Microsphere market?
5. Who are the key producers in the global Radioembolization Microsphere market?
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Supply Summary
1.1 Radioembolization Microsphere Introduction
1.2 World Radioembolization Microsphere Supply & Forecast
1.2.1 World Radioembolization Microsphere Production Value (2019 & 2023 & 2030)
1.2.2 World Radioembolization Microsphere Production (2019-2030)
1.2.3 World Radioembolization Microsphere Pricing Trends (2019-2030)
1.3 World Radioembolization Microsphere Production by Region (Based on Production Site)
1.3.1 World Radioembolization Microsphere Production Value by Region (2019-2030)
1.3.2 World Radioembolization Microsphere Production by Region (2019-2030)
1.3.3 World Radioembolization Microsphere Average Price by Region (2019-2030)
1.3.4 North America Radioembolization Microsphere Production (2019-2030)
1.3.5 Europe Radioembolization Microsphere Production (2019-2030)
1.3.6 China Radioembolization Microsphere Production (2019-2030)
1.3.7 Japan Radioembolization Microsphere Production (2019-2030)
1.4 Âé¶¹Ô´´ Drivers, Restraints and Trends
1.4.1 Radioembolization Microsphere Âé¶¹Ô´´ Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radioembolization Microsphere Major Âé¶¹Ô´´ Trends
2 Demand Summary
2.1 World Radioembolization Microsphere Demand (2019-2030)
2.2 World Radioembolization Microsphere Consumption by Region
2.2.1 World Radioembolization Microsphere Consumption by Region (2019-2024)
2.2.2 World Radioembolization Microsphere Consumption Forecast by Region (2025-2030)
2.3 United States Radioembolization Microsphere Consumption (2019-2030)
2.4 China Radioembolization Microsphere Consumption (2019-2030)
2.5 Europe Radioembolization Microsphere Consumption (2019-2030)
2.6 Japan Radioembolization Microsphere Consumption (2019-2030)
2.7 South Korea Radioembolization Microsphere Consumption (2019-2030)
2.8 ASEAN Radioembolization Microsphere Consumption (2019-2030)
2.9 India Radioembolization Microsphere Consumption (2019-2030)
3 World Radioembolization Microsphere Manufacturers Competitive Analysis
3.1 World Radioembolization Microsphere Production Value by Manufacturer (2019-2024)
3.2 World Radioembolization Microsphere Production by Manufacturer (2019-2024)
3.3 World Radioembolization Microsphere Average Price by Manufacturer (2019-2024)
3.4 Radioembolization Microsphere Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Radioembolization Microsphere Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Radioembolization Microsphere in 2023
3.5.3 Global Concentration Ratios (CR8) for Radioembolization Microsphere in 2023
3.6 Radioembolization Microsphere Âé¶¹Ô´´: Overall Company Footprint Analysis
3.6.1 Radioembolization Microsphere Âé¶¹Ô´´: Region Footprint
3.6.2 Radioembolization Microsphere Âé¶¹Ô´´: Company Product Type Footprint
3.6.3 Radioembolization Microsphere Âé¶¹Ô´´: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Âé¶¹Ô´´ Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Radioembolization Microsphere Production Value Comparison
4.1.1 United States VS China: Radioembolization Microsphere Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Radioembolization Microsphere Production Value Âé¶¹Ô´´ Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Radioembolization Microsphere Production Comparison
4.2.1 United States VS China: Radioembolization Microsphere Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Radioembolization Microsphere Production Âé¶¹Ô´´ Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Radioembolization Microsphere Consumption Comparison
4.3.1 United States VS China: Radioembolization Microsphere Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Radioembolization Microsphere Consumption Âé¶¹Ô´´ Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Radioembolization Microsphere Manufacturers and Âé¶¹Ô´´ Share, 2019-2024
4.4.1 United States Based Radioembolization Microsphere Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Radioembolization Microsphere Production Value (2019-2024)
4.4.3 United States Based Manufacturers Radioembolization Microsphere Production (2019-2024)
4.5 China Based Radioembolization Microsphere Manufacturers and Âé¶¹Ô´´ Share
4.5.1 China Based Radioembolization Microsphere Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Radioembolization Microsphere Production Value (2019-2024)
4.5.3 China Based Manufacturers Radioembolization Microsphere Production (2019-2024)
4.6 Rest of World Based Radioembolization Microsphere Manufacturers and Âé¶¹Ô´´ Share, 2019-2024
4.6.1 Rest of World Based Radioembolization Microsphere Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Radioembolization Microsphere Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Radioembolization Microsphere Production (2019-2024)
5 Âé¶¹Ô´´ Analysis by Type
5.1 World Radioembolization Microsphere Âé¶¹Ô´´ Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Holmium 166 Microspheres
5.2.2 Yttrium 90 Microspheres
5.2.3 Others
5.3 Âé¶¹Ô´´ Segment by Type
5.3.1 World Radioembolization Microsphere Production by Type (2019-2030)
5.3.2 World Radioembolization Microsphere Production Value by Type (2019-2030)
5.3.3 World Radioembolization Microsphere Average Price by Type (2019-2030)
6 Âé¶¹Ô´´ Analysis by Application
6.1 World Radioembolization Microsphere Âé¶¹Ô´´ Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Liver Tumors
6.2.2 Liver Cancer
6.2.3 Others
6.3 Âé¶¹Ô´´ Segment by Application
6.3.1 World Radioembolization Microsphere Production by Application (2019-2030)
6.3.2 World Radioembolization Microsphere Production Value by Application (2019-2030)
6.3.3 World Radioembolization Microsphere Average Price by Application (2019-2030)
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Details
7.1.2 Boston Scientific Major Business
7.1.3 Boston Scientific Radioembolization Microsphere Product and Services
7.1.4 Boston Scientific Radioembolization Microsphere Production, Price, Value, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
7.1.5 Boston Scientific Recent Developments/Updates
7.1.6 Boston Scientific Competitive Strengths & Weaknesses
7.2 Quirem Medical
7.2.1 Quirem Medical Details
7.2.2 Quirem Medical Major Business
7.2.3 Quirem Medical Radioembolization Microsphere Product and Services
7.2.4 Quirem Medical Radioembolization Microsphere Production, Price, Value, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
7.2.5 Quirem Medical Recent Developments/Updates
7.2.6 Quirem Medical Competitive Strengths & Weaknesses
7.3 ABK Biomedical
7.3.1 ABK Biomedical Details
7.3.2 ABK Biomedical Major Business
7.3.3 ABK Biomedical Radioembolization Microsphere Product and Services
7.3.4 ABK Biomedical Radioembolization Microsphere Production, Price, Value, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
7.3.5 ABK Biomedical Recent Developments/Updates
7.3.6 ABK Biomedical Competitive Strengths & Weaknesses
7.4 Chengdu New Radiomedicine Technology Co.,Ltd.
7.4.1 Chengdu New Radiomedicine Technology Co.,Ltd. Details
7.4.2 Chengdu New Radiomedicine Technology Co.,Ltd. Major Business
7.4.3 Chengdu New Radiomedicine Technology Co.,Ltd. Radioembolization Microsphere Product and Services
7.4.4 Chengdu New Radiomedicine Technology Co.,Ltd. Radioembolization Microsphere Production, Price, Value, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
7.4.5 Chengdu New Radiomedicine Technology Co.,Ltd. Recent Developments/Updates
7.4.6 Chengdu New Radiomedicine Technology Co.,Ltd. Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Radioembolization Microsphere Industry Chain
8.2 Radioembolization Microsphere Upstream Analysis
8.2.1 Radioembolization Microsphere Core Raw Materials
8.2.2 Main Manufacturers of Radioembolization Microsphere Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Radioembolization Microsphere Production Mode
8.6 Radioembolization Microsphere Procurement Model
8.7 Radioembolization Microsphere Industry Sales Model and Sales Channels
8.7.1 Radioembolization Microsphere Sales Model
8.7.2 Radioembolization Microsphere Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Boston Scientific
Quirem Medical
ABK Biomedical
Chengdu New Radiomedicine Technology Co.,Ltd.
Ìý
Ìý
*If Applicable.